Abstract Body

Antiretroviral therapy (ART) and retention in care are essential for prevention of mother-to-child HIV transmission (PMTCT). In a randomized trial, we assessed the impact of a family-focused, integrated PMTCT care package on maternal ART initiation, post-partum mother-infant pair retention and infant HIV infection.

We pair-matched 12 sites, randomizing clinic-pairs to intervention vs. control (SOC) arms. Standard-of-care (SOC) services included: group provision of health information; opt-out HIV testing with same-day results; infant feeding counseling; referral to hub centers for CD4/treatment initiation; home-based care services; infant prophylaxis and early infant diagnosis. Intervention sites received SOC plus (a) Point-of-care CD4+cell count testing; (b) de-evolution of decentralized PMTCT tasks to trained lower-cadre providers; (c) integrated mother-infant care; and (d) active male partner and community involvement. A generalized linear mixed effects model with random effect for matched clinic-pairs was used to determine intervention effects for maternal ART initiation and retention of mother–infant pairs at 6- and 12-weeks postpartum.

We enrolled 369 participants (n=172, intervention; n= 197, SOCl). Participants were comparable across arms for marital status, time of HIV diagnosis, and distance to facility.  Enrolment median CD4+ cell count was higher in intervention mothers than in SOC (424 cells/μL (IQR: 268-606) vs. 314 cells/μL (IQR: 245-406), p<0.001). Most participants were WHO clinical stage 1 (98%), of high functional status (working/ambulatory, 99%), and delivered vaginally (96%). After adjusting for age, education, travel time to facility, employment, maternal ethnicity, and time of HIV diagnosis, intervention mothers were significantly more likely to initiate ART than SOC (Relative Risk, RR [95% Confidence Interval, CI]= 3.3 [1.4-7.8]). Mother-infant pairs in the intervention arm had comparatively higher likelihood than SOC arm pairs of being retained in care at 6- and 12-weeks postpartum (RR=9.1 [5.2-15.9] and 10.3 [5.4-19.7], respectively). At the 12 week visit, 2.4% (95% CI: 0.9-6.3%) of infants tested HIV-positive in the intervention arm vs. 7.3% (95% CI: 3.3-15.6%) in the control arm.

This integrated, family-focused service package improved maternal ART uptake and retention and reduced infant HIV infection.